Short- and long-term outcomes following robotic and open resection for intrahepatic cholangiocarcinoma: A national cohort study.


Journal

Surgical oncology
ISSN: 1879-3320
Titre abrégé: Surg Oncol
Pays: Netherlands
ID NLM: 9208188

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 07 01 2022
revised: 09 05 2022
accepted: 06 06 2022
pubmed: 20 6 2022
medline: 14 9 2022
entrez: 19 6 2022
Statut: ppublish

Résumé

Curative-intent liver resection with porta hepatis lymphadenectomy provides the best chance for long-term survival for patients with intrahepatic cholangiocarcinoma (ICC). While the robotic approach has been increasingly utilized, its impact on perioperative and long-term outcomes of patients with ICC are largely unknown. Patients with stages I-III ICC who underwent surgical resection between 2004 and 2017 were identified from the National Cancer Database. Descriptive statistics and multivariate models were constructed to examine the association between surgical approach and surgical and oncological outcomes. A total of 1876 patients with ICC who underwent open (n = 1804, 96.2%) and robotic-assisted (n = 72, 3.8%) resection were identified. Following surgery, patients who underwent a robotic-assisted resection had a shorter length of hospital stay yet there was no difference in 30-day readmission or 90-day mortality. Older age, disease stage, and higher comorbidity were associated with worse OS. Patients undergoing robotic-assisted surgery had no difference in long-term risk of death compared with patients who underwent an open procedure. This national cohort study demonstrated that the robotic approach for patients undergoing resection for ICC resulted in a shorter hospitalization while not compromising oncological outcomes such as negative margins, postoperative mortality, and long-term survival.

Sections du résumé

BACKGROUND BACKGROUND
Curative-intent liver resection with porta hepatis lymphadenectomy provides the best chance for long-term survival for patients with intrahepatic cholangiocarcinoma (ICC). While the robotic approach has been increasingly utilized, its impact on perioperative and long-term outcomes of patients with ICC are largely unknown.
METHODS METHODS
Patients with stages I-III ICC who underwent surgical resection between 2004 and 2017 were identified from the National Cancer Database. Descriptive statistics and multivariate models were constructed to examine the association between surgical approach and surgical and oncological outcomes.
RESULTS RESULTS
A total of 1876 patients with ICC who underwent open (n = 1804, 96.2%) and robotic-assisted (n = 72, 3.8%) resection were identified. Following surgery, patients who underwent a robotic-assisted resection had a shorter length of hospital stay yet there was no difference in 30-day readmission or 90-day mortality. Older age, disease stage, and higher comorbidity were associated with worse OS. Patients undergoing robotic-assisted surgery had no difference in long-term risk of death compared with patients who underwent an open procedure.
CONCLUSION CONCLUSIONS
This national cohort study demonstrated that the robotic approach for patients undergoing resection for ICC resulted in a shorter hospitalization while not compromising oncological outcomes such as negative margins, postoperative mortality, and long-term survival.

Identifiants

pubmed: 35717859
pii: S0960-7404(22)00084-6
doi: 10.1016/j.suronc.2022.101790
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101790

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Auteurs

Ahmad Hamad (A)

Department of Surgery, The Ohio State University, Columbus, OH, USA.

Aliya Ansari (A)

Department of Surgery, The Ohio State University, Columbus, OH, USA.

Yaming Li (Y)

Department of Surgery, The Ohio State University, Columbus, OH, USA.

Chengli Shen (C)

Department of Surgery, The Ohio State University, Columbus, OH, USA.

Jordan Cloyd (J)

Department of Surgery, The Ohio State University, Columbus, OH, USA.

Timothy M Pawlik (TM)

Department of Surgery, The Ohio State University, Columbus, OH, USA.

Aslam Ejaz (A)

Department of Surgery, The Ohio State University, Columbus, OH, USA. Electronic address: aslam.ejaz@osumc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH